Locations

MENDHAM

Private financing in MENDHAM, aggregated from public sources.

$158.2M
Capital raised
9
Companies
15
Rounds
2008
First on record
2023-03-13
Latest round

— MENDHAM drew — over the last 12 months. Of 9 companies rankable against same-niche peers, 33% model over-valued and 33% under-valued.

Capital flow over time

Quarterly capital raised in MENDHAM.

2008-Q2 · $3.0M2008-Q22010-Q1 · $6.2M2010-Q12010-Q2 · $15.1M2010-Q22010-Q4 · $135K2010-Q42012-Q3 · $5.7M2012-Q32015-Q4 · $150K2015-Q42018-Q4 · $15.0M2018-Q42020-Q3 · $4.9M2020-Q32021-Q2 · $32.0M2021-Q22021-Q4 · $75.0M2021-Q42023-Q1 · $1.0M2023-Q1
Sector mix
SectorCompaniesRoundsCapital
Pharmaceuticals410$150.8M
Other Health Care12$5.7M
Retailing11$1.0M
Other22$630K
Top-funded companies
CompanySectorRaisedModeled value
Antios Therapeutics Inc.Pharmaceuticals$126.4M$1.7B
Edgemont Pharmaceuticals, LLCPharmaceuticals$6.2M$150.1M
Oceana Therapeutics, Inc.Pharmaceuticals$3.0M$114.1M
Mig Irc, LlcOther Health Care$5.7M$86.0M
Orchid BioAdvisory, LLCOther$480K$10.1M
Follica, IncPharmaceuticals$15.2M$4.2M
Klox LLCOther Technology$2.0M$3.9M
Metro Business, Inc.Retailing$1.0M$3.7M
Cideroad, LLCOther$150K$3.5M
Other locations
SAN FRANCISCO$186.4BNEW YORK$184.6BBOSTON$44.5BNew York$39.7BAUSTIN$29.3BCHICAGO$28.9BLOS ANGELES$27.7BCAMBRIDGE$24.7B

Browse all locations or the full company rankings.

Frequently asked
How much venture funding have companies in MENDHAM raised?
Companies based in MENDHAM have raised approximately $158.2M across 15 recorded financing rounds among 9 companies, aggregated from public sources.
What sectors are most active in MENDHAM?
The most active sectors in MENDHAM by recorded financing are Pharmaceuticals, Other Health Care, Retailing, Other. See the sector mix table for company and round counts.
Which are the most-funded companies in MENDHAM?
The most-funded MENDHAM companies in our coverage include Antios Therapeutics Inc., Edgemont Pharmaceuticals, LLC, Oceana Therapeutics, Inc., Mig Irc, Llc, Orchid BioAdvisory, LLC. See the ranked table for disclosed capital and modeled valuations.